Food-packed tables and endless spirits can present a special challenge for those taking GLP-1 medications like Wegovy, ...

And that's why Amazon is a top tech stock to buy and hold for 2026 and beyond.

Eli Lilly leads incretins via Zepbound/Mounjaro, retatrutide at 28.7% loss, $50B R&D and US buildout, 2025 guidance, ...

Phoenix NP announced a continued rise in patient satisfaction across Arizona, noting that positive feedback has increased as more women seek safe, FDA-approved GLP-1 weight loss medications through ...

Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a ...

Retatrutide, originally developed by Eli Lilly, has found a loyal fan base—even though clinical trials of the drug still ...

Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and ...

The company also said earlier this week it will drop $6 billion on a new manufacturing facility in Huntsville, Alabama.

Mark Kerr is a championship wrestler, former UFC champion, and is portrayed by Dwayne “The Rock” Johnson in the recently ...

Tan France is using his experience in fashion way beyond styling. Now, the Queer Eye staple is partnering with Lilly, the ...

A proposed new federal law could provide some competitive guardrails for the company's most important product.

Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce ...